Skip to main content
Premium Trial:

Request an Annual Quote

Linguamatics Announces $10M in 2013 Sales

Premium

Linguamatics said this week that it exceeded $10 million in sales last year outperforming both growth and sales expectations.

The company said in a statement that its increased sales came from a "boost in new customers and increased software licenses to existing customers in the pharmaceutical and healthcare sectors." This included 130 percent growth in healthcare sales plus increased sales in professional services, Linguamatics said.

Linguamatics developed and sells I2E, a software platform that uses natural language processing to identify and extract information from unstructured text such as scientific literature, patents, clinical trials data, electronic health records, news feeds, social media, and proprietary content and put it into a structured format for further analysis.

The company's customer base includes pharmaceutical companies, the US Food and Drug Administration, hospitals, cancer institutes, and academic research centers.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.